Cargando…

SHP2 is involved in the occurrence, development and prognosis of cancer

Src homology-2 domain-containing protein tyrosine phosphatase (SHP2), encoded by protein tyrosine phosphatase non-receptor type 11 (PTPN11), is widely expressed in several human tissue types, and plays an important role in a variety of diseases. The present study assessed the impact of SHP2 on the o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shu, Qu, Jialing, Wang, Xiaotong, Zou, Qin, Li, Chunli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433711/ https://www.ncbi.nlm.nih.gov/pubmed/37600341 http://dx.doi.org/10.3892/ol.2023.13979

Ejemplares similares

Role of SHP2/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta-analysis
por: Li, Shu, et al.
Publicado: (2022)

SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer
por: Huang, Yan, et al.
Publicado: (2017)

Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development
por: Deng, Rong, et al.
Publicado: (2015)

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023)

Developing SHP2-based combination therapy for KRAS-amplified cancer
por: Li, Tianxia, et al.
Publicado: (2023)

Functions of Shp2 in cancer
por: Zhang, Jie, et al.
Publicado: (2015)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2–Induced Gastrulation Defects
por: Jopling, Chris, et al.
Publicado: (2007)

Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles
por: Hu, ZhongQian, et al.
Publicado: (2019)

The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma: A meta-analysis
por: Li, Shu, et al.
Publicado: (2020)

SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer
por: Geng, Qian, et al.
Publicado: (2022)

Expression levels of caspase‐3 and gasdermin E and their involvement in the occurrence and prognosis of lung cancer
por: Huang, Yuan‐Li, et al.
Publicado: (2021)

New Insights into Orphan Nuclear Receptor SHP in Liver Cancer
por: Zou, An, et al.
Publicado: (2015)

SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development
por: Gagné-Sansfaçon, Jessica, et al.
Publicado: (2016)

Sidestepping SHP2 inhibition
por: Popescu, Bogdan, et al.
Publicado: (2023)

Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis
por: Liu, Xia, et al.
Publicado: (2011)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations
por: Bauler, Timothy J., et al.
Publicado: (2011)

Involvement of glutathione peroxidases in the occurrence and development of breast cancers
por: Zhang, Man-Li, et al.
Publicado: (2020)

Intraarticular injection of SHP2 inhibitor SHP099 promotes the repair of rabbit full-thickness cartilage defect
por: Sun, Ziying, et al.
Publicado: (2022)

Function of fibroblast growth factor 2 in gastric cancer occurrence and prognosis
por: Li, Yang, et al.
Publicado: (2020)

Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation
por: Patsoukis, Nikolaos, et al.
Publicado: (2020)

Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
por: Taylor, Julia, et al.
Publicado: (2023)

Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
por: Xu, Xiaozheng, et al.
Publicado: (2021)

Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022)

PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2
por: Xu, Xiaozheng, et al.
Publicado: (2020)

The correlation between multiple HPV infections and the occurrence, development, and prognosis of cervical cancer
por: Na, Jing, et al.
Publicado: (2023)

Protein-protein interaction between caveolin-1 and SHP-2 is dependent on the N-SH2 domain of SHP-2
por: Park, Hyunju, et al.
Publicado: (2015)

Shp1 in Solid Cancers and Their Therapy
por: Varone, Alessia, et al.
Publicado: (2020)

Skeletal malformation and the SHP-2 pathway
Publicado: (2011)

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014)

Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP
por: Zhang, Yuxia, et al.
Publicado: (2012)

Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved “backdoor” cysteine
por: Yarnall, Matthew T.N., et al.
Publicado: (2022)

Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity
por: Miao, Jinmin, et al.
Publicado: (2023)

Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles
por: Hu, ZhongQian, et al.
Publicado: (2018)

Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation
por: Sha, Fern, et al.
Publicado: (2023)

SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo
por: Hu, ZhongQian, et al.
Publicado: (2017)

SHP-1 is a target of regorafenib in colorectal cancer
por: Fan, Li-Ching, et al.
Publicado: (2014)

The MADS Box Genes ABS, SHP1, and SHP2 Are Essential for the Coordination of Cell Divisions in Ovule and Seed Coat Development and for Endosperm Formation in Arabidopsis thaliana
por: Ehlers, Katrin, et al.
Publicado: (2016)

Targeting SHP2 phosphatase in Myeloproliferative Neoplasms
por: Mali, Raghuveer Singh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rfhe8hmh268hc3sb8tgvphlmco